Objective To investigate individual and concomitant risk factors for hearing loss during
neonatal care. Design Case–control study. Setting Community. Population 237 children …

Background: Aminoglycoside-induced ototoxicity has been reported in neonates but its
incidence is poorly defined, whereas vancomycin-induced ototoxicity has not been reported …

The most prominent feature of neonatal clinical pharmacology is huge variability in
pharmacokinetics and pharmacodynamics of frequently used medicines due to rapid growth …

Objective To evaluate the prevalence of non-approved prescriptions (off-label and
unlicensed) in a neonatal intensive care unit (NICU), and to describe factors of the neonate …

Background Many drugs used for neonates are unlicensed or off‐label. An increased risk of
medication errors and unexpected adverse drug reactions is associated with their use. This …

Newborn babies who need intensive medical care are often sheltered into a special area of
the hospital called Neonatal Intensive Care Unit (NICU). In this structure, babies are …

Introduction: Gentamicin and the other aminoglycosides are toxic antibiotics, but they are
urgently needed to treat newborns with neonatal sepsis. Aminoglycosides are well known …

Ototoxicity is defined as the damage, reversible or irreversible, produced in the inner ear by
various substances that are called ototoxic and that can cause hearing loss and/or an …

Purpose This study aims to describe the drug use on a Neonatal Intensive Care Unit (NICU)
at a University Children's Hospital in Germany, to investigate the licensing status of the …

OBJECTIVE: To determine the status of drug use in Neonatology units regarding: 1.
Frequency of use for drugs unauthorised by DirecciA (3) n General de Farmacia y Productos …